Cerenome is trading 5.54% down at $2.81, amid broader market weakness with no clear company-specific catalyst identified for September 4, 2026.
- Opened below the September 3 close of $2.98.
- A stronger-than-expected August jobs report lifted Treasury yields and revived Federal Reserve rate-hike concerns; the broader market’s decline is moderate.
- Recent quarterly revenue and earnings misses remain background pressure, not a confirmed cause.